| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,798 |
58,271 |
$5.49M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,203 |
29,929 |
$3.56M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
3,347 |
2,999 |
$1.91M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,943 |
12,254 |
$1.78M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,823 |
3,414 |
$1.47M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,838 |
21,386 |
$1.39M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,248 |
7,376 |
$998K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
10,165 |
9,040 |
$920K |
| 71045 |
Radiologic examination, chest; single view |
34,405 |
30,660 |
$889K |
| 80053 |
Comprehensive metabolic panel |
86,562 |
75,185 |
$590K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,564 |
1,445 |
$550K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,043 |
1,818 |
$525K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
36,075 |
29,154 |
$468K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,414 |
9,043 |
$450K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
876 |
772 |
$447K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
29,833 |
24,374 |
$386K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,390 |
14,522 |
$384K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
77,772 |
67,070 |
$381K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
1,316 |
831 |
$317K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,554 |
14,589 |
$311K |
| 83880 |
|
16,815 |
14,951 |
$307K |
| 59025 |
Fetal non-stress test |
4,388 |
2,851 |
$251K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,075 |
5,640 |
$220K |
| 84484 |
|
30,154 |
22,799 |
$188K |
| 36415 |
Collection of venous blood by venipuncture |
91,942 |
75,254 |
$159K |
| 93458 |
|
185 |
162 |
$143K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,529 |
3,242 |
$130K |
| 80050 |
General health panel |
2,911 |
2,782 |
$117K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,184 |
5,563 |
$114K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
258 |
227 |
$112K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,665 |
3,990 |
$107K |
| 87581 |
|
3,514 |
3,246 |
$100K |
| 87486 |
|
3,520 |
3,253 |
$100K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,246 |
2,926 |
$95K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,064 |
881 |
$86K |
| 81001 |
|
45,363 |
37,844 |
$84K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
349 |
328 |
$83K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,787 |
5,377 |
$82K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
554 |
537 |
$76K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,471 |
1,202 |
$68K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,269 |
10,063 |
$63K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
264 |
236 |
$61K |
| 83690 |
|
11,772 |
10,533 |
$55K |
| 80061 |
Lipid panel |
4,577 |
4,308 |
$54K |
| 82077 |
|
6,140 |
5,000 |
$53K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,793 |
1,664 |
$51K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,003 |
945 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,005 |
945 |
$41K |
| 82550 |
|
10,817 |
8,864 |
$35K |
| 85730 |
|
12,684 |
11,130 |
$34K |
| 83605 |
|
5,993 |
4,467 |
$34K |
| 87040 |
|
5,824 |
3,042 |
$32K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
505 |
468 |
$31K |
| 85610 |
|
15,189 |
13,307 |
$31K |
| 84703 |
|
4,808 |
4,376 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
635 |
593 |
$29K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
700 |
660 |
$27K |
| 85027 |
|
5,520 |
4,705 |
$27K |
| 83735 |
|
7,794 |
6,561 |
$27K |
| 74022 |
|
595 |
543 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
973 |
861 |
$25K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
73 |
65 |
$24K |
| 87081 |
|
3,833 |
3,457 |
$24K |
| 82553 |
|
4,538 |
3,540 |
$23K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,538 |
8,946 |
$18K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
73 |
70 |
$18K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
480 |
360 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
93 |
85 |
$16K |
| 81025 |
|
2,426 |
2,159 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
938 |
892 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,665 |
1,578 |
$15K |
| 76801 |
|
212 |
191 |
$13K |
| G0378 |
Hospital observation service, per hour |
52 |
36 |
$12K |
| C1760 |
Closure device, vascular (implantable/insertable) |
469 |
405 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,088 |
11,952 |
$10K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
213 |
183 |
$10K |
| 80143 |
|
853 |
744 |
$9K |
| 80179 |
|
784 |
701 |
$9K |
| 95951 |
|
26 |
26 |
$8K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
28 |
26 |
$8K |
| C1769 |
Guide wire |
734 |
644 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
331 |
233 |
$8K |
| 82607 |
|
520 |
499 |
$7K |
| 80074 |
|
141 |
138 |
$7K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
462 |
92 |
$7K |
| 84702 |
|
525 |
464 |
$7K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
31 |
26 |
$7K |
| 82785 |
|
387 |
360 |
$6K |
| 36600 |
|
668 |
521 |
$6K |
| 96376 |
|
541 |
317 |
$6K |
| 84439 |
|
579 |
549 |
$6K |
| 82805 |
|
1,177 |
988 |
$5K |
| 80177 |
|
399 |
358 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$5K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
19 |
13 |
$4K |
| 95713 |
|
27 |
27 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
155 |
148 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
826 |
722 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,447 |
2,102 |
$4K |
| 82043 |
|
642 |
616 |
$4K |
| 86850 |
|
1,246 |
897 |
$4K |
| 64483 |
|
46 |
39 |
$3K |
| 84100 |
|
1,674 |
1,421 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
16 |
12 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,088 |
1,647 |
$3K |
| 82570 |
|
666 |
630 |
$3K |
| 82375 |
|
552 |
482 |
$3K |
| 86140 |
|
828 |
742 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
520 |
389 |
$3K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
320 |
282 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
40 |
28 |
$2K |
| 80183 |
|
179 |
170 |
$2K |
| 86900 |
|
1,601 |
1,202 |
$2K |
| 73630 |
|
109 |
97 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,986 |
4,242 |
$2K |
| 86901 |
|
1,588 |
1,190 |
$2K |
| 76000 |
|
159 |
145 |
$2K |
| 86003 |
|
47 |
38 |
$2K |
| 87070 |
|
232 |
213 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,190 |
1,031 |
$2K |
| 83050 |
|
542 |
476 |
$2K |
| 87807 |
|
131 |
130 |
$2K |
| 86696 |
|
72 |
66 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
30 |
26 |
$2K |
| 93017 |
|
12 |
12 |
$1K |
| 82150 |
|
380 |
335 |
$1K |
| 87186 |
|
193 |
160 |
$1K |
| 84145 |
|
98 |
81 |
$1K |
| 80164 |
|
100 |
93 |
$1K |
| 85379 |
|
198 |
175 |
$1K |
| 86694 |
|
73 |
66 |
$1K |
| 72100 |
|
27 |
24 |
$1K |
| 86695 |
|
72 |
66 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
92 |
74 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
241 |
219 |
$940.08 |
| 74018 |
|
32 |
26 |
$889.11 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,267 |
1,011 |
$873.19 |
| 86780 |
|
56 |
54 |
$818.60 |
| 83615 |
|
796 |
688 |
$734.57 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
15 |
15 |
$726.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,540 |
3,257 |
$725.62 |
| 85045 |
|
164 |
151 |
$701.12 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,588 |
8,625 |
$664.04 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
53 |
52 |
$649.33 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
111 |
108 |
$614.14 |
| 81003 |
|
312 |
203 |
$602.96 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
715 |
620 |
$583.99 |
| 82728 |
|
74 |
66 |
$534.26 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
630 |
564 |
$491.67 |
| 74019 |
|
15 |
15 |
$485.43 |
| J2704 |
Injection, propofol, 10 mg |
3,960 |
2,046 |
$473.55 |
| 73562 |
|
17 |
14 |
$370.17 |
| 82962 |
|
238 |
138 |
$366.29 |
| 86592 |
|
72 |
66 |
$337.39 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
20 |
13 |
$319.09 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
67 |
63 |
$318.56 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
16 |
14 |
$284.03 |
| 72170 |
|
15 |
12 |
$260.89 |
| 85652 |
|
97 |
96 |
$231.97 |
| J2060 |
Injection, lorazepam, 2 mg |
122 |
105 |
$202.28 |
| 85018 |
|
1,142 |
723 |
$198.34 |
| 82746 |
|
16 |
13 |
$191.94 |
| 87077 |
|
12 |
12 |
$145.74 |
| 84550 |
|
30 |
29 |
$135.38 |
| 87205 |
|
25 |
25 |
$118.32 |
| 85651 |
|
27 |
26 |
$98.64 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
381 |
287 |
$89.03 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
12 |
$46.43 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$31.74 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
25 |
24 |
$18.73 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
17 |
13 |
$14.51 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$5.91 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
20 |
12 |
$4.02 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,145 |
898 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
1,281 |
890 |
$0.00 |
| 02414 |
|
180 |
166 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
90 |
69 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
30 |
12 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
53 |
25 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
672 |
556 |
$0.00 |
| A9270 |
Non-covered item or service |
257 |
241 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
21 |
13 |
$0.00 |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
21 |
13 |
$0.00 |
| 97010 |
|
30 |
13 |
$0.00 |